Abeona Therapeutics Inc.
ABEO
$4.78
$0.183.91%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 52.23M | 53.75M | 36.77M | 40.36M | 52.15M |
Total Receivables | 2.44M | 2.21M | 5.73M | 519.00K | 188.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 729.00K | 963.00K | 1.20M | 1.62M | 424.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 338.00K | 338.00K | 338.00K | 338.00K | 338.00K |
Total Current Assets | 55.74M | 57.26M | 44.04M | 42.84M | 53.10M |
|
|||||
Total Current Assets | 55.74M | 57.26M | 44.04M | 42.84M | 53.10M |
Net Property, Plant & Equipment | 7.99M | 8.68M | 9.40M | 10.40M | 11.07M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 277.00K | 139.00K | 108.00K | 99.00K | 43.00K |
Total Assets | 64.00M | 66.09M | 53.55M | 53.35M | 64.21M |
|
|||||
Total Accounts Payable | 1.86M | 2.59M | 3.48M | 2.86M | 1.81M |
Total Accrued Expenses | 5.99M | 3.97M | 4.16M | 2.57M | 3.99M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 998.00K | 1.65M | 1.60M | 1.79M | 1.77M |
Total Finance Division Other Current Liabilities | 4.58M | 199.00K | 205.00K | 205.00K | 204.00K |
Total Other Current Liabilities | 4.58M | 199.00K | 205.00K | 205.00K | 204.00K |
Total Current Liabilities | 13.42M | 8.41M | 9.44M | 7.42M | 7.78M |
|
|||||
Total Current Liabilities | 13.42M | 8.41M | 9.44M | 7.42M | 7.78M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.40M | 4.04M | 4.38M | 5.53M | 5.85M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 31.35M | 31.59M | 30.39M | 21.66M | 23.82M |
Total Liabilities | 49.18M | 44.05M | 44.21M | 34.61M | 37.45M |
|
|||||
Common Stock & APIC | 764.42M | 755.07M | 730.54M | 723.25M | 722.23M |
Retained Earnings | -749.52M | -732.93M | -721.10M | -704.44M | -695.34M |
Treasury Stock & Other | -66.00K | -99.00K | -95.00K | -65.00K | -129.00K |
Total Common Equity | 14.83M | 22.04M | 9.35M | 18.74M | 26.76M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.83M | 22.04M | 9.35M | 18.74M | 26.76M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 14.83M | 22.04M | 9.35M | 18.74M | 26.76M |
|